Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel factor Xa inhibitors for treatment of thromboembolic disorders

Feb. 15, 2002

Factor Xa inhibitors for thromboembolic disorders synthesized at DuPont

Feb. 14, 2002

Fibrolase derivative under joint development by Hyseq and Amgen as thrombolytic

Feb. 13, 2002

Spotlight on tPA and stroke at ISC

Feb. 13, 2002

Eptifibatide protects patients one year after coronary stent implantation

Feb. 12, 2002

Pyrazole derivatives prepared at DuPont for thromboembolic disorders

Feb. 12, 2002

Beneficial effects and safety demonstrated for gpIIb/IIIa antagonist in acute ischemic stroke

Feb. 12, 2002

Argatroban reduces stroke-associated mortality in HIT patients

Feb. 12, 2002

Arixtra introduced in the U.S. for preventing thromboembolic events following surgery

Feb. 11, 2002

Addition of SM-20302 to tPA associated with beneficial outcome in thromboembolic stroke

Feb. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...